Previous findings have demonstrated that conventional therapies, such as chemotherapy‐mediated upregulation of cell surface calreticulin and radiotherapy‐induced inflammation, increased the sensitivity of the tumour to macrophages, all of which contributed to the outcomes of anti‐CD47 treatment [44]. This evidence concerns the gene CD47 and neoplasm.